Independent pharmaceutical news and regulatory intelligence covering Africa.
Watching Medicines. Protecting Africa. Recalls, agency alerts, regulation, medicine quality and industry intelligence — filed daily from across the continent.
Active alerts and recalls
Verified against the issuing agency’s published notice.
- November 3, 2026
- Alerts & Recalls
Egypt flags unknown-source Epoetin vials and MEBO ointment packs
Egypt’s Drug Authority (EDA) has issued two commercial fraud circulars over packs of unknown source, after the manufacturers named on […]
- November 3, 2026
- Alerts & Recalls
SAHPRA recalls one batch of Esenta Stomahesive Paste over foreign matter risk
The South African Health Products Regulatory Authority has ordered a Class II Type C recall of batch 5L00431 of Esenta Stomahesive...
- October 30, 2026
- Alerts & Recalls
AMMPS recalls one batch of Pfizer’s Nivestim over cold-chain temperature recording incident
Morocco's medicines regulator has ordered an immediate halt to distribution and use of batch NG0631 of Nivestim 30 MU/0.5 ml after...
- October 30, 2026
- Alerts & Recalls
Egypt issues six fraud notices covering Ibrance, Cialis and four other products
The Egyptian Drug Authority has recalled specific batches of Lipotropic medicines after identifying commercial fraud, warning that the alert applies only...
- October 30, 2026
- Alerts & Recalls
ERIS orders permanent withdrawal of Lauroderme nappy cream batch 03725
Cape Verde's health regulator has ordered the permanent withdrawal of batch 03725 of Lauroderme nappy cream after investigations failed to confirm...
- October 27, 2026
- Alerts & Recalls
SAHPRA recalls two batches of Levoneptin gabapentin over impurity levels
The South African Health Products Regulatory Authority has ordered a Class II Type B recall of two batches of Levoneptin gabapentin...
- October 16, 2026
- Alerts & Recalls
AMMPS recalls one batch of Vinrab rabies immunoglobulin over non-conformity
The Agence Marocaine du Médicament et des Produits de Santé has ordered a batch recall of Vinrab rabies immunoglobulin after detecting...
- October 15, 2026
- Alerts & Recalls
ANPP recalls one batch of Arovan atorvastatin over quality defect
The Agence Nationale des Produits Pharmaceutiques has ordered a batch recall of Arovan atorvastatin 10 mg tablets after identifying a quality...
How we verify
Sourced from the issuing agency
Every alert is matched to a published notice from the national regulator that issued it.
Corrections on the record
Updates and corrections are timestamped on the article rather than made silently.
Latest
- November 4, 2026
- Regulatory
Morocco’s AMMPS lifts suspension of nine Novopharma products
The Agence Marocaine du Médicament et des Produits de Santé has lifted suspensions on nine Novopharma products after verifying the manufacturer's corrective and...
- November 3, 2026
- Alerts & Recalls
Egypt flags unknown-source Epoetin vials and MEBO ointment packs
Egypt’s Drug Authority (EDA) has issued two commercial fraud circulars over packs of unknown source, after the manufacturers named on […]
- November 3, 2026
- Alerts & Recalls
SAHPRA recalls one batch of Esenta Stomahesive Paste over foreign matter risk
The South African Health Products Regulatory Authority has ordered a Class II Type C recall of batch 5L00431 of Esenta Stomahesive Paste after...
- November 3, 2026
- Regulatory
Algeria’s ANPP appoints Dr Lina Farhat to African Medicines Agency technical committee
The Agence Nationale des Produits Pharmaceutiques has appointed Dr Lina Farhat as expert and deputy chair of the African Medicines Agency's technical committee...
- November 3, 2026
- Regulatory
Faso FDA seeks partner support to reach WHO maturity level 3
Burkina Faso's medicines and food regulator has presented its strategic priorities to technical and financial partners, seeking support to achieve WHO Maturity Level...
- November 3, 2026
- Industry
CEPI adds $8.2 million to Africa CDC hub-and-spoke clinical trial network
The Coalition for Epidemic Preparedness Innovations will provide up to US$8.2 million to the International Vaccine Institute and MRC Unit The Gambia to...
What we cover
Daily coverage of pharmaceutical developments from across Africa, filed under four sections.
Alerts & Recalls
Recalls, falsified medicines, agency alerts and import holds — with batch numbers.
Regulatory
Approvals, registrations, inspections, licensing, policy and medical devices.
Quality & Safety
Surveillance surveys, pharmacovigilance, laboratory findings and adverse reactions.
Industry
Manufacturing, clinical research, market intelligence, procurement and access.
Topics within them
Regulatory Affairs
Updates from national medicines regulatory authorities, policy changes, product registrations, inspections, licensing and compliance.
Drug Safety
Medicine recalls, pharmacovigilance reports, adverse drug reactions and patient safety alerts.
Medicine Quality
Investigations into substandard and falsified medicines, laboratory findings, quality assurance and quality control.
Local Manufacturing
Coverage of pharmaceutical production, technology transfer, API manufacturing, investment opportunities and industrial development.
Clinical Research
Clinical trials, research findings, ethics, innovation and scientific publications.
Medical Devices
Medical device regulation, standards, inspections, innovation and healthcare technologies.
Market Intelligence
Market trends, pharmaceutical business analysis, procurement, supply chains, imports, exports and investment insights.
Public Health
Health policies, disease control, vaccination, medicine accessibility and healthcare systems.
Regulatory alerts and news, direct to your inbox
Independent pharmaceutical news and regulatory intelligence covering Africa.